CLINICAL TRIALS PROFILE FOR SILDENAFIL CITRATE

All Clinical Trials for SILDENAFIL CITRATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00057759 ↗	Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer	Completed	National Cancer Institute (NCI)	N/A	2003-01-01	RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910.
NCT00057759 ↗	Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer	Completed	Radiation Therapy Oncology Group	N/A	2003-01-01	RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910.
NCT00080808 ↗	Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer	Completed	National Cancer Institute (NCI)	Phase 2	2001-08-01	RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer.
NCT00080808 ↗	Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer	Completed	M.D. Anderson Cancer Center	Phase 2	2001-08-01	RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate cancer improve sexual satisfaction and quality of life. It is not yet known whether erectile dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve grafting. PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to see how well they work compared to standard therapy alone in treating erectile dysfunction in patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer.
NCT00104637 ↗	Sildenafil for Chronic Obstructive Pulmonary Disease	Completed	Pfizer	Phase 2	2005-02-01	The purpose of this study is to determine if sildenafil improves the exercise capacity and lung function of patients with chronic obstructive pulmonary disease.
NCT00104637 ↗	Sildenafil for Chronic Obstructive Pulmonary Disease	Completed	Kawut, Steven, MD	Phase 2	2005-02-01	The purpose of this study is to determine if sildenafil improves the exercise capacity and lung function of patients with chronic obstructive pulmonary disease.
NCT00123162 ↗	Viagra in the Treatment of Primary Dysmenorrhea	Completed	National Institutes of Health (NIH)	Phase 1/Phase 2	2007-05-01	The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.

Clinical Trial Conditions for SILDENAFIL CITRATE

Condition Name

Condition Name for SILDENAFIL CITRATE
Intervention	Trials
Erectile Dysfunction	19
Impotence	12
Pulmonary Arterial Hypertension	10
Pulmonary Hypertension	9

Condition MeSH

Condition MeSH for SILDENAFIL CITRATE
Intervention	Trials
Erectile Dysfunction	34
Hypertension	27
Hypertension, Pulmonary	16
Pulmonary Arterial Hypertension	14

Clinical Trial Locations for SILDENAFIL CITRATE

Trials by Country

Trials by Country for SILDENAFIL CITRATE
Location	Trials
United States	207
United Kingdom	37
Egypt	22
Mexico	21
Spain	20

Trials by US State

Trials by US State for SILDENAFIL CITRATE
Location	Trials
Texas	15
California	14
New York	12
Massachusetts	11
Ohio	10

Clinical Trial Progress for SILDENAFIL CITRATE

Clinical Trial Phase

Clinical Trial Phase for SILDENAFIL CITRATE
Clinical Trial Phase	Trials
Phase 4	42
Phase 3	24
Phase 2/Phase 3	6

Clinical Trial Status

Clinical Trial Status for SILDENAFIL CITRATE
Clinical Trial Phase	Trials
Completed	81
Unknown status	18
Terminated	12

Clinical Trial Sponsors for SILDENAFIL CITRATE

Sponsor Name

Sponsor Name for SILDENAFIL CITRATE
Sponsor	Trials
Pfizer	45
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	32
Ain Shams University	8

Sponsor Type

Sponsor Type for SILDENAFIL CITRATE
Sponsor	Trials
Other	117
Industry	92
NIH	8